Novo Nordisk: Clinical Research Associate
About the Company
Novo Nordisk is building a talent pool for future Clinical Research Associate (CRA) positions. By applying to the pipeline, candidates will be considered for all current and upcoming CRA roles. Applications will be kept for six months, ensuring the best match for open positions.
Position Name:
Clinical Research Associate
Organization:
Novo Nordisk
Qualification:
- B.Pharm, M.Pharm, Pharm.D
- M.Sc, B.Sc
- Lifesciences
Experience:
- 2-3 years
Salary:
- Not disclosed
Location:
- Bangalore
Role and Responsibilities
| Responsibility | Description |
|---|---|
| Primary Contact | Serve as the main point of contact between site staff and Novo Nordisk, acting as an ambassador for the company. |
| Site Management | Lead site management for the selection, initiation, conduction, and closure activities of studies, ensuring compliance with local regulations, ICH-GCP, NN procedures, and protocol requirements. |
| Recruitment and Results | Responsible for recruitment at the site level and delivering results that impact the successful completion of the clinical program. |
| Coordination | Coordinate with CRM and RTM, communicating progress and critical issues that may affect trial progress. |
| Site Visits | Conduct efficient and accurate site selection visits, including analysis of site logistics and performance. |
| Patient Recruitment | Develop and implement patient recruitment strategies and mitigation actions. |
| Monitoring Activities | Regularly visit trial sites to perform required monitoring activities. |
| IT Systems | Use IT systems (e.g., IMPACT, EDC) proactively for site visit preparation, conduct, and source data verification in collaboration with the data management/logistics team. |
Qualifications
- Education: Graduate in Medicine, Science, Pharmacy, or another relevant field.
- Certifications: Certified in ICH GCP; additional qualifications in clinical research preferred.
- Experience: 2-4 years as a Clinical Research Associate, with experience in 1-2 multinational clinical trials (phase 2-3) from site initiation to closure.